Business Context and Reporting Period
This Form 8-K filing by Expedia, Inc. (now Expedia Group, Inc.) was submitted on March 6, 2018, reporting events that occurred on March 2, 2018. The filing focuses exclusively on executive compensation matters regarding Robert Dzielak, the Company's Chief Legal Officer and Secretary.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data provided relates to executive compensation:
- Base Salary Increase: Mr. Dzielak's annual base salary was increased from $600,000 to $700,000, effective February 26, 2018.
- Target Bonus: Remained unchanged at 100% of base salary.
- Stock Option Exercise Price: $104.50 per share (closing price on the date of grant).
Material Changes
The primary material change reported is the execution of an Amended and Restated Employment Agreement with Robert Dzielak, replacing his prior agreement which expired on March 2, 2018. Key changes include:
- Severance Terms: Upon termination without Cause or resignation for Good Reason, the Company will pay 12 months of base salary (discretionarily extendable to 18 months), accelerate equity vesting for the 12-month post-termination period, and provide 12 months of COBRA coverage.
- Equity Grants: Significant new equity awards were approved, including 12,747 Restricted Stock Units (RSUs) and 172,784 stock options split into three categories: Annual Vest, Cliff Vest, and Performance-Based Options.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or general risk factors. Specific contingencies and performance metrics include:
- Performance-Based Options: 51,280 options are contingent on stock price targets of $200 (91% increase) or $180 (72% increase) by September 2021.
- Restrictive Covenants: Mr. Dzielak is restricted from competing with the Company and soliciting employees until the end of the Salary Continuation Period.
- Termination Conditions: Employment may be terminated at any time with or without cause or notice.
Investor Verification Checklist
- Verify the total dilution impact of the 172,784 new stock options and 12,747 RSUs granted to Mr. Dzielak.
- Review the specific definitions of "Cause" and "Good Reason" in the attached Exhibit 10.1 to understand severance triggers.
- Assess the feasibility of the performance-based stock price targets ($180 and $200) relative to the $104.50 grant price.
- Confirm the total potential cash severance liability (12-18 months of $700,000 salary plus pro-rated bonus) in the event of a termination without Cause.